Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advanced Cell Technology, Inc.
Advanced Cell Technology Completes Private Placement
April 20th, 2008
Advanced Cell Technology, Inc. (OTCBB:ACTC) announced that it completed a private placement with institutional and other accredited investors. The company intends to use the proceeds of the offering towards for general corporate purposes, including additions to working capital, and to finance the further development of the company's clinical programs. Advanced Cell Technology closed on the private placement of $3,855,360 principal amount of amortizing senior secured convertible debentures. The issuance of the debentures generated $3,072,000 in gross proceeds. William M. Caldwell, IV, Chairman and CEO of Advanced Cell Technology remarked, "This...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-20)
|
